Rodriguez Stephanie N, Jiang Meizi, Bujo Hideaki, Allen Paul M
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, United States.
Department of Clinical-Laboratory and Experimental-Research Medicine, Toho University, Sakura Medical Center, Sakura, Japan.
Mol Immunol. 2015 Feb;63(2):428-36. doi: 10.1016/j.molimm.2014.09.016. Epub 2014 Oct 22.
Self-peptide MHCII ligands are critical for selection of CD4+ T cells in the thymus, and maintenance in the periphery. To date, no investigation as to the exact thymic and peripheral expression of a naturally occurring positive selecting self-peptide MHCII (self-pMHCII) complex has taken place. We have generated a sensitive T cell hybridoma to functionally detect the endogenous presentation of a confirmed positive selecting self-pMHCII complex for a CD4+ transgenic T cell. Using this tool to survey and quantify the expression selecting of self-pMHCII, we have shown unequivocal proof that a known CD4+ selecting ligand can be presented on both positive and negative selecting thymic APCs. We also show that peripheral presentation of this same selecting ligand is affected by the activation state of the APCs. Furthermore, discrepancies between the gene expression and self-pMHCII complex presentation of this bona fide selecting ligand suggest that functional detection self-ligand complexes will be required to establish a complete view of the naturally presented endogenous self-pMHC landscape.
自身肽MHCII配体对于胸腺中CD4+ T细胞的选择以及外周的维持至关重要。迄今为止,尚未对天然存在的阳性选择自身肽MHCII(自身pMHCII)复合物在胸腺和外周的确切表达进行研究。我们构建了一种敏感的T细胞杂交瘤,以功能检测已确认的针对CD4+转基因T细胞的阳性选择自身pMHCII复合物的内源性呈递。使用该工具来调查和量化自身pMHCII的表达选择,我们已经明确证明,一种已知的CD4+选择配体可以在阳性和阴性选择的胸腺抗原呈递细胞上呈递。我们还表明,这种相同选择配体的外周呈递受抗原呈递细胞激活状态的影响。此外,这种真正选择配体的基因表达与自身pMHCII复合物呈递之间的差异表明,需要进行功能性检测自身配体复合物,以全面了解天然呈递的内源性自身pMHC格局。